PGEN

Neutral

Precigen CEO set for J.P. Morgan and Goldman Sachs healthcare fireside chats

Precigen (Nasdaq: PGEN), a biopharmaceutical company, announced its CEO, Helen Sabzevari, will participate in two upcoming investor events. These incl...

Stock Titan 2 weeks ago 0

Neutral

Precigen to Participate in Fireside Chats with J.P. Morgan and at the Goldman Sachs 47th Annual Global Healthcare Conference

Precigen, Inc. announced its participation in two upcoming investor events: a J.P. Morgan virtual fireside chat on June 1st and the Goldman Sachs 47th...

PR Newswire 2 weeks ago 0